帕金森病纳米技术的最新进展:诊断,治疗和未来的前景
Virendra Kumar Yadav1, Seshathiri Dhanasekaran2, Nisha Choudhary3
1Faculty of Sciences, Department of Microbiology, Marwadi University Research Center, Marwadi University, Rajkot, Gujarat, India.
Frontiers in medicine
|February 6, 2025
概括
纳米医学为帕金森病的治疗提供了一种有前途的方法,通过利用纳米粒子在血脑屏障上提供向药物. 这种先进的疗法旨在通过提高药物的生物可用性和减少副作用来克服当前治疗方法的局限性.
科学领域:
- 神经科学是一个神经科学.
- 生物医学工程 生物医学工程
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕金森病 (PD) 是一种进展性神经退行性疾病,影响黑体质中的多巴胺基神经元,导致发和硬等运动症状.
- 目前的PD治疗专注于症状管理,但往往会导致副作用和疾病进展.
- 传统治疗方法的局限性需要新的帕金森病治疗策略.
研究的目的:
- 审查纳米医学在治疗帕金森病中的潜力.
- 突出纳米技术如何克服与传统帕金森病治疗相关的挑战.
- 探索纳米医学的应用与基因治疗对帕金森病的结合.
主要方法:
- 对帕金森病新兴纳米医学应用的审查.
- 纳米粒子特性 (大小,表面积) 对于血脑屏障透的分析.
- 对各种纳米载体系统 (脂质体,纳米凝,树突体,固体脂质纳米粒子) 进行检查,以控制药物输送.
主要成果:
- 纳米颗粒可以被设计成穿越血脑屏障,使得治疗药物的向输送到受影响的大脑区域.
- 多种纳米粒子类型 (基于脂质,聚合物,金属,碳) 显示出对帕金森病治疗的前景.
- 纳米载体系统有助于控制和持续释放药物,提高疗效和减少不良影响.
结论:
- 纳米医学在帕金森病治疗方面取得了重大进展,提供有针对性的治疗和改善治疗结果.
- 纳米医学与基因治疗的整合有可能在帕金森病中进行创新干预.
- 对纳米医学的进一步研究对于开发更有效的帕金森病治疗方法至关重要.
相关概念视频
Parkinson's Disease: Overview
447
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
447
Parkinson's Disease: Treatment
192
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
192
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Alzheimer's Disease: Overview
437
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
437
Alzheimer's Disease: Treatment
158
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
158
Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K


